HUTCHMED (China) (HCM) Current Assets (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Current Assets of $1.6 billion for Q2 2026, down 2.44% year-over-year from $1.6 billion in Q2 2025, and down 0.89% quarter-over-quarter from $1.6 billion in Q4 2025.
HUTCHMED (China) (HCM) Current Assets (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Current Assets for 12 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Assets fell 2.44% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $1.6 billion (down 2.44% YoY), while the FY2025 annual figure was $1.6 billion, down 100.0% from the prior year.
- Current Assets slipped to $1.6 billion in Q2 2026 per HCM's latest filing, from $1.6 billion in the prior quarter.
- Across five years, Current Assets topped out at $163901.0 billion in Q4 2024 and bottomed at -$73.8 million in Q4 2023.
- Historically, Current Assets has averaged $18212.2 billion across 5 years, with a median of $1.1 billion in 2023.
- Annual changes were most pronounced in 2023 — Current Assets tumbled 108.78% — and 2024, when it soared 222162735.55%.
- HUTCHMED (China)'s Current Assets stood at $839.9 million in 2022, then slumped by 108.78% to -$73.8 million in 2023, then jumped by 222162735.55% to $163901.0 billion in 2024, then slumped by 100.0% to $1.6 billion in 2025, then retreated by 0.89% to $1.6 billion in 2026.
- Business Quant data shows HCM's Current Assets at $1.6 billion in Q2 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | 1.55 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Bn |
| Dec 31, 2025 | 1.57 Bn |
| Jun 30, 2025 | 1.59 Bn |
| Dec 31, 2024 | 163,900.96 Bn |
| Jun 30, 2024 | 1.05 Bn |
| Dec 31, 2023 | -73.78 Mn |
| Jun 30, 2023 | 1.09 Bn |
| Dec 31, 2022 | 839.89 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Jun 30, 2021 | 1.09 Bn |
| Mar 31, 2021 | 496.23 Mn |
| Dec 31, 2020 | 530.74 Mn |
| Jun 30, 2020 | 374.73 Mn |
| Dec 31, 2019 | 317.02 Mn |
| Sep 30, 2019 | 277.08 Mn |
| Jun 30, 2019 | 309.50 Mn |
| Mar 31, 2019 | 349.99 Mn |
| Dec 31, 2018 | 370.54 Mn |
| Jun 30, 2018 | 394.68 Mn |